ILMN 140.14 (+2.3%)
US4523271090Medical Diagnostics & ResearchDiagnostics & Research

Illumina (ILMN) Competitor Comparison

We are evaluating the key criteria listed to compare Illumina (ILMN) against its competitors in the Diagnostics & Research industry.

Performance 3 years - ILMN ranking 33 / 58

These are the competitors of Illumina in the industry Diagnostics & Research ranked by performance 3 years
1. Meridian Bioscience VIVO
246.63
2. Lantheus Holdings LNTH
203.72
3. RadNet RDNT
184.17
4. Natera NTRA
61.37
5. Medpace Holdings MEDP
48.69
6. Heska HSKA
41.31
7. PerkinElmer PKI
21.19
8. Ortho Clinical Diagnostics Holdings OCDX
13.74
9. Quest Diagnostics DGX
10.43
10. Waters WAT
6.71
11. Laboratory Corp of America Holdings LH
-1.13
12. Danaher DHR
-15.23
13. Bioventus BVS
-18.02
14. Agilent Technologies A
-18.88
15. Syneos Health SYNH
-19.01
16. Thermo Fisher Scientific TMO
-19.8
17. Mettler-Toledo MTD
-21.48
18. Olink Holding OLK
-22.2
19. Qiagen QGEN
-23.88
20. IQVIA Holdings IQV
-25
21. Icon ICLR
-25.68
22. Anixa Biosciences ANIX
-27.14
23. IDEXX Laboratories IDXX
-35.28
24. Exact Sciences EXAS
-37.51
25. Sera Prognostics SERA
-44.45
26. Sotera Health SHC
-45.33
27. Myriad Genetics MYGN
-46.12
28. CareDx CDNA
-47.12
29. Charles River Laboratories CRL
-48.4
30. DexCom DXCM
-54.38
31. National Research NRC
-54.62
32. Twist Bioscience TWST
-58.81
33. Illumina ILMN
-61.87
34. NeoGenomics NEO
-61.99
35. Interpace Biosciences IDXG
-65.64
36. Neogen NEOG
-67.11
37. Global Cord Blood CO
-67.25
38. Exagen XGN
-67.52
39. Guardant Health GH
-68.41
40. Enzo Biochem ENZ
-70.36
41. MaxCyte MXCT
-72.81
42. Psychemedics PMD
-73.1
43. Personalis PSNL
-78.62
44. Biodesix BDSX
-81.42
45. Fulgent Genetics FLGT
-81.73
46. MDxHealth MDXH
-82.37
47. Precipio PRPO
-84.62
48. bioAffinity Technologies BIAF
-85.24
49. Trinity Biotech TRIB
-86.73
50. Co-Diagnostics CODX
-88.14
51. Organovo Holdings ONVO
-89.19
52. Neuronetics STIM
-91.07
53. Pacific Biosciences of California PACB
-93.27
54. DarioHealth DRIO
-93.77
55. Inotiv NOTV
-94.29
56. SeqLL SQL
-95.69
57. Prenetics Global PRE
-96.16
58. Aspira Womens Health AWH
-98.83

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.